Seaport Therapeutics, Inc. (SPTX)

NASDAQ: SPTX · Real-Time Price · USD

24.88

+1.27 (5.38%)

At close: Sep 2, 2026, 4:00 PM EDT

24.91

+0.03 (0.12%)

After-hours: Sep 2, 2026, 4:10 PM EDT

Seaport Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Selling, General & Admin	57.57	20.98	27.35
Research & Development	86.33	64.42	25.07
Operating Expenses	143.9	85.4	52.42
Operating Income	-143.9	-85.4	-52.42
Interest & Investment Income	10.72	11.4	5.54
Other Non Operating Income (Expenses)	-3.56	-3.55	-
EBT Excluding Unusual Items	-136.74	-77.54	-46.88
Gain (Loss) on Sale of Investments	3.43	3.43	-
Pretax Income	-133.31	-74.11	-46.88
Income Tax Expense	1.38	0.77	-
Net Income	-134.69	-74.88	-46.88
Net Income to Common	-134.69	-74.88	-46.88
Net Income Growth	-	-	-
Shares Outstanding (Basic)	16	7	3
Shares Outstanding (Diluted)	16	7	3
Shares Change	-	151.76%	-
EPS (Basic)	-8.50	-10.04	-15.83
EPS (Diluted)	-8.50	-10.04	-15.83
EPS Growth	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Free Cash Flow	-88.76	-78.3	-29.74
Free Cash Flow Per Share	-5.60	-10.50	-10.04
EBITDA	-143.75	-85.22	-52.25
D&A For EBITDA	0.15	0.17	0.17
EBIT	-143.9	-85.4	-52.42

SEC Filings: 10-K · 10-Q